Hybrid Nitric Oxide Donor and its Carrier for the Treatment of Peripheral Arterial Diseases

Nitric oxide (NO) has been known to promote physiological angiogenesis to treat peripheral arterial diseases (PAD) by increasing the vascular endothelial growth factor (VEGF) level in endothelial cells (ECs) and preventing platelet adherence and leukocyte chemotaxis. However, the ongoing ischemic ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Le, Duong Q., Kuriakose, Aneetta E., Nguyen, Dat X., Nguyen, Kytai T., Acharya, Suchismita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562917/
https://www.ncbi.nlm.nih.gov/pubmed/28821752
http://dx.doi.org/10.1038/s41598-017-08441-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562917/
https://www.ncbi.nlm.nih.gov/pubmed/28821752
http://dx.doi.org/10.1038/s41598-017-08441-9

Ejemplares similares